MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202641072999 A) filed by K. Kalpana on June 12, 2026, for Exploring The Potential Of Nanocellulose Modified Mxenes For Cancer Therapy.
Inventors include Dr. K. Kalpana; Dr. G. Jagadeesan; and Dr. P. Sugumar.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: ABSTRACT The uncontrolled proliferation and dissemination of abnormal cells within the body define the complex spectmm of diseases referred to as cancer. The invasion of neighbouring tissues and organs by these cells may dismpt normal bodily functions. A variety of reasons, such as genetic abnormalities, exposure to the environment, lifestyle decisions, and infections, can lead to cancerous growths in nearly any portion of the body. Since ancient times, cancer has posed a serious threat to human survival, there has been constant research being done in an attempt to find better treatments. Traditional cancer treatment and diagnostic methods include chemotherapy, surgical procedures, hormonal therapy, immunotherapy, and radiation therapy, as well as imaging techniques such as photoacoustic imaging (PA), magnetic resonance imaging (MRI) and computed tomography (CT). Though, there may be certain drawbacks to these routes, such as high toxicity, low biocompatibility, low sensitivity or selectivity, low drug bioavailability, multidrug resistance, off-target effects, high dose requirements, etc. These issues have led researchers to devise and investigate efficient substitute approaches or systems with precise targeting qualities to lessen the likelihood -of off-target effects and enhance multifunctionality. Numerous therapeutic and diagnostic agents based on nanoscale and nanostructures have been produced in the last 20 years. Nanoparticles have demonstrated benefits in the process of diagnosing and/or cancer treatment as compared to traditional modalities. Now a days two-dimensionalnanomaterials, like black phosphorus, hexagonal boron nitride flatlands, graphene, dichalcogenides, MXenes, antimonenes and metal oxides,have been employed as attractive and promising frameworks for photothermal therapy and cancer chemotherapy because of their good photothermal conversion efficiency, large specific surface areas, good biocompatibility, and acceptable biodegradability.Among these materials, transition metal carbides and nitrides are commonly known as MXenes, an expanding group of two-dimensional materials. Typically, MXenes exhibit multi-layered structures characterized by exceptional metallic conductivity due to their unbound electrons, along with hydrophilic properties attributed to surface terminations
Disclaimer: Curated by HT Syndication.
